Optimising Survival and Quality of Survival for Children with Wilms Tumour Through Biomarker Research and Clinical Trials

被引：0
|
作者：
Pritchard-Jones, Kathy [1 ]
机构：
[1] UCL, Great Ormond St Inst Child Hlth, London, England
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SY6-1
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 50 条
  • [41] LIVING WITH REGULATIONS - SURVIVAL THROUGH QUALITY
    FORD, D
    LABORATORY ANIMALS, 1987, 21 (02) : 167 - 168
  • [42] Vessel calibre—a potential MRI biomarker of tumour response in clinical trials
    Kyrre E. Emblem
    Christian T. Farrar
    Elizabeth R. Gerstner
    Tracy T. Batchelor
    Ronald J. H. Borra
    Bruce R. Rosen
    A. Gregory Sorensen
    Rakesh K. Jain
    Nature Reviews Clinical Oncology, 2014, 11 : 566 - 584
  • [43] Improved survival for patients with recurrent Wilms tumor: The experience at St. Jude children's research hospital
    Dome, JS
    Liu, TB
    Krasin, M
    Lott, L
    Shearer, P
    Daw, NC
    Billups, CA
    Wilimas, JA
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (03) : 192 - 198
  • [44] CLINICAL TRIALS WITH CYCLOPHOSPHAMIDE (CYTOXAN) IN CHILDREN WITH WILMS TUMOR - PRELIMINARY REPORT
    HADDY, TB
    WHITAKER, JA
    VIETTI, JA
    RILEY, HD
    CANCER CHEMOTHERAPY REPORTS, 1962, (25): : 81 - 85
  • [45] IRGM promotes melanoma cell survival through autophagy and is a promising prognostic biomarker for clinical application
    Tian, Linlu
    Meng, Hongxue
    Dong, Xiao
    Li, Xinlei
    Shi, Zilin
    Li, Hulun
    Zhang, Lie
    Yang, Yue
    Liu, Ruijie
    Pei, Chunying
    Li, Bo
    Xu, Hongwei
    Li, Rui
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 : 187 - 198
  • [46] Clinical Outcomes of Children with Wilms Tumour Treated in a Tertiary Care Hospital in Nigeria
    Nasir, A.
    Toyin, N. Abdulraheem
    Abdur-Rahman, L. O.
    Adedoyin, T. O.
    Adeniran, J. O.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S374 - S374
  • [47] The Clinical Impact of Observer Variability in Lung Nodule Classification in Children With Wilms Tumour
    Brok, J.
    Shelmeridine, S.
    Damsgaard, F.
    Smets, A.
    Irtan, S.
    Swinson, S.
    Hedayati, V.
    Jacob, J.
    Nair, A.
    Oostveen, M.
    Pritchard-Jones, K.
    Olsen, O.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S68 - S68
  • [48] CLINICAL FEATURES AND OUTCOMES OF WILMS TUMOUR IN CHILDREN WITH WAGR SPECTRUM DISORDER IN RUSSIA
    Elfimova, Anna
    Sagoyan, Garik
    Semenova, Vera
    Kozlova, Valentina
    Kirgizov, Kirill
    Rubanskaya, Marina
    Varfolomeeva, Svetlana
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S563 - S563
  • [49] Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
    Chen, TT
    Simon, RM
    Korn, EL
    Anderson, SJ
    Lindblad, AS
    Wieand, HS
    Douglass, HO
    Fisher, B
    Hamilton, JM
    Friedman, MA
    COMMUNICATIONS IN STATISTICS-THEORY AND METHODS, 1998, 27 (06) : 1363 - 1378
  • [50] The clinical impact of observer variability in lung nodule classification in children with Wilms tumour
    Brok, Jesper Sune
    Shelmerdine, Susan
    Damsgaard, Frederikke
    Smets, Anne
    Irtan, Sabine
    Swinson, Sophie
    Hedayati, Venus
    Jacob, Joseph
    Nair, Arjun
    Oostveen, Minou
    Pritchard-Jones, Kathy
    Olsen, Oystein
    PEDIATRIC BLOOD & CANCER, 2022, 69 (10)
12345